What is Afatinib Dimaleate 40 mg?
Afatinib Dimaleate 40 mg is a prescription medication used primarily in the treatment of non-small cell lung cancer (NSCLC). It contains the active ingredient Afatinib Dimaleate, which belongs to a class of drugs known as tyrosine kinase inhibitors. These agents help to target and disrupt cancer cell growth at the molecular level.
Developed and manufactured by Boehringer Ingelheim India Pvt.Ltd, Afatinib Dimaleate 40 mg is designed to provide a targeted therapeutic option for patients diagnosed with specific types of NSCLC. Its availability and use in Canada have made it an important part of lung cancer management in clinical oncology.
Uses of Afatinib Dimaleate 40 mg
- Treatment of advanced or metastatic non-small cell lung cancer (NSCLC)
- Managing NSCLC with specific epidermal growth factor receptor (EGFR) mutations
- As a targeted therapy for patients who have not previously received other tyrosine kinase inhibitors
How Afatinib Dimaleate 40 mg Works
Afatinib Dimaleate 40 mg functions by irreversibly binding to the tyrosine kinase domain of the epidermal growth factor receptor family, which is instrumental in the growth and proliferation of cancer cells. By inhibiting these receptors, Afatinib blocks the chemical signals that promote tumor growth.
This targeted approach allows for more effective interruption of cancer progression while minimizing damage to normal, healthy cells. The drug’s mechanism is particularly effective against NSCLC tumors harboring mutations in the EGFR gene.
Benefits of Afatinib Dimaleate 40 mg
- Effective inhibition of tumor growth in EGFR-positive NSCLC
- Improved progression-free survival rates in patients
- Oral administration offers ease of use compared to intravenous chemotherapy
- Targeted therapy with fewer systemic side effects than conventional treatments
- Provides a treatment option for patients resistant to other EGFR inhibitors
Dosage and Administration
The recommended dose of Afatinib Dimaleate 40 mg is one tablet taken orally once daily, preferably at the same time each day. The tablets should be swallowed whole with water and may be taken with or without food.
Dosing may be adjusted based on patient tolerance and adverse effects. It is critical to follow the treating physician’s instructions precisely and never self-adjust the dose. Regular monitoring during treatment is essential to evaluate efficacy and side effects.
Who Should Use Afatinib Dimaleate 40 mg?
Afatinib Dimaleate 40 mg is intended for adult patients diagnosed with non-small cell lung cancer exhibiting specific EGFR mutations. It is especially suitable for those requiring targeted therapy to inhibit tumor growth. Patients who have not responded to other first-line treatments may also benefit from this medication.
Who Should Avoid Afatinib Dimaleate 40 mg?
Patients with known hypersensitivity to Afatinib or any of its components should avoid using this drug. It is not recommended for individuals with severe liver impairment unless supervised by a healthcare professional. Pregnant or breastfeeding women should consult their doctor before using Afatinib Dimaleate 40 mg due to potential risks to the fetus or infant.
Side Effects
- Diarrhea
- Skin rash
- Mouth sores
- Nausea
- Fatigue
- Dry skin
- Loss of appetite
- Eye irritation
- Weight loss
- Dermatitis
Safety Advice
- Notify your healthcare provider immediately if severe diarrhea occurs
- Maintain adequate hydration during treatment
- Avoid sun exposure and use sunscreen due to skin sensitivity
- Do not discontinue treatment without consulting your doctor
- Inform your doctor about all other medications you are taking to avoid interactions
- Report any unusual bleeding or bruising promptly
Drug Interactions
- Medications that reduce stomach acid may affect Afatinib absorption
- CYP450 enzyme inhibitors or inducers can alter drug levels
- Other cancer therapies might increase side effect risks
- St. John’s Wort and similar supplements should be avoided
Storage Instructions
Store Afatinib Dimaleate 40 mg tablets in a cool, dry place below 25°C. Keep the medication in its original container, tightly closed, and out of reach of children and pets. Avoid exposure to excessive heat, moisture, or direct sunlight to preserve efficacy.
Where to buy Afatinib Dimaleate 40 mg in Canada?
Afatinib Dimaleate 40 mg is available through licensed Canadian pharmacies with a valid prescription. Patients may also explore reputable online pharmacies that comply with Canadian regulations. Always ensure purchasing from authorized vendors to guarantee genuine product quality and safety.
Frequently Asked Questions (FAQ)
Is Afatinib Dimaleate 40 mg available in Canada?
Yes, Afatinib Dimaleate 40 mg is available in Canada with a prescription. It can be obtained through licensed pharmacies and some approved online platforms.
What is the price of Afatinib Dimaleate 40 mg in Canada?
The price varies depending on the supplier and whether it is purchased through private insurance or government programs. It is advisable to check with multiple pharmacies for pricing and insurance coverage.
What happens if I miss a dose?
If you miss a dose, take it as soon as you remember on the same day. Do not double the next dose to make up for a missed one. If it is near the time for your next dose, skip the missed dose and continue as scheduled.
Where can I find Afatinib Dimaleate 40 mg for sale?
You can purchase Afatinib Dimaleate 40 mg at licensed pharmacies in Canada or through verified online pharmaceutical retailers that require a prescription.
Can I take Afatinib Dimaleate 40 mg with other medications?
Some medications can interact with Afatinib. Always inform your healthcare provider about all the drugs and supplements you take to avoid potential interactions.
Are there any dietary restrictions while using Afatinib Dimaleate 40 mg?
No strict dietary restrictions are necessary, but managing hydration and avoiding alcohol may help reduce side effects. Always follow your healthcare provider’s guidance.
How long is Afatinib Dimaleate 40 mg treatment prescribed?
The duration depends on individual response and disease progression and is determined by the treating oncologist. Regular monitoring is essential to assess treatment effectiveness.
Conclusion
Afatinib Dimaleate 40 mg is a targeted therapeutic agent designed to manage non-small cell lung cancer effectively, particularly in patients with EGFR mutations. Its specific mechanism of action and oral administration form offer a promising option in modern cancer treatment. Proper medical supervision, adherence to prescribed dosage, and awareness of possible side effects contribute to optimal outcomes when using this medication.
Leave A Review